← Leaderboards
Jody D. Ciolino
Northwestern University At Chicago
$7,003,382
Attributed
$14,365,384
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.5M · FY2018–25$5M$3.8M$2.5M$1.3M$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,365,384 · 4
By mechanism
U24$8,744,314 · 1
R33$3,316,760 · 1
R61$1,228,452 · 1
R01$1,075,858 · 1
Top collaborators
- Mark D Huffman5 shared
- Daniela P Ladner4 shared
- Howard S Kim2 shared
- Scott Travis Youngquist2 shared
Most similar at Northwestern University At Chicago
Same institution · by research overlap
- James William Griffith$7,291,641
- Mark D Huffman$8,566,817
- Melissa A. Simon$40,197,785
- Matthew James Smith$4,967,646
- Howard S Kim$3,081,332
Others in their field
Other Emerging Leaders on “Research Personnel”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Joel A Lipkin · Four Points Technology, Llc$178,737,225
- Lynn Briscoe · Leidos Biomedical Research, Inc.$160,201,956
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$123,112,727
Research focus
Research PersonnelSiteSafetyUnited StatesUniversitiesResourcesPreventMemberEventBiometryLeadReportingPublic HealthTrainingTreatment StrategyPharmaceutical PreparationsHybridsHuman ResourcesProspectiveClinical TrialsAmericanChicagoProtocols DocumentationFoundations
Grant awards (11)
A Multi-Site Feasibility Trial of Embedded Emergency Department Physical Therapy for Back Pain$497,367
R01 · FY2025 · AT
Liver Cirrhosis Network: Scientific and Data Coordination Center$2,192,940
U24 · FY2024 · DK · contact PI
A Multi-Site Feasibility Trial of Embedded Emergency Department Physical Therapy for Back Pain$578,491
R01 · FY2024 · AT
Liver Cirrhosis Network: Scientific and Data Coordination Center$2,064,403
U24 · FY2023 · DK · contact PI
A double-blind randomized controlled trial to assess the efficacy and safety of a quadruple ultra-low dose treatment for hypertension (QUARTET USA)$544,107
R33 · FY2023 · HL
Liver Cirrhosis Network: Scientific and Data Coordination Center$2,096,971
U24 · FY2022 · DK · contact PI
A double-blind randomized controlled trial to assess the efficacy and safety of a quadruple ultra-low dose treatment for hypertension (QUARTET USA)$629,010
R33 · FY2022 · HL
Liver Cirrhosis Network: Scientific and Data Coordination Center$2,390,000
U24 · FY2021 · DK · contact PI
A double-blind randomized controlled trial to assess the efficacy and safety of a quadruple ultra-low-dose treatment for hypertension (QUARTET USA)$1,104,047
R33 · FY2021 · HL
A double-blind randomized controlled trial to assess the efficacy and safety of a quadruple ultra-low-dose treatment for hypertension (QUARTET USA)$1,039,596
R33 · FY2019 · HL
A double-blind randomized controlled trial to assess the efficacy and safety of a quadruple ultra-low-dose treatment for hypertension (QUARTET USA)$1,228,452
R61 · FY2018 · HL